Louisiana State Employees Retirement System Sells 300 Shares of Humana Inc. (NYSE:HUM)

Louisiana State Employees Retirement System trimmed its holdings in shares of Humana Inc. (NYSE:HUM) by 4.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,800 shares of the insurance provider’s stock after selling 300 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Humana were worth $2,541,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the business. &PARTNERS bought a new position in shares of Humana in the second quarter worth approximately $380,000. Private Advisory Group LLC bought a new position in shares of Humana in the 2nd quarter worth $7,293,000. Fifth Third Wealth Advisors LLC bought a new position in shares of Humana in the 2nd quarter worth $549,000. Fifth Third Bancorp raised its position in shares of Humana by 41.7% during the 2nd quarter. Fifth Third Bancorp now owns 10,659 shares of the insurance provider’s stock valued at $3,983,000 after buying an additional 3,135 shares in the last quarter. Finally, Commerzbank Aktiengesellschaft FI lifted its holdings in shares of Humana by 245.5% during the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 6,968 shares of the insurance provider’s stock worth $2,604,000 after acquiring an additional 4,951 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Price Performance

HUM stock opened at $352.90 on Friday. The firm’s 50-day moving average price is $367.72 and its two-hundred day moving average price is $346.47. Humana Inc. has a 12-month low of $298.61 and a 12-month high of $530.54. The stock has a market capitalization of $42.52 billion, a price-to-earnings ratio of 21.97, a PEG ratio of 2.09 and a beta of 0.51. The company has a current ratio of 1.66, a quick ratio of 1.67 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm had revenue of $29.54 billion for the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter in the previous year, the company earned $8.94 earnings per share. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities analysts predict that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date is Monday, September 30th. Humana’s payout ratio is 22.04%.

Wall Street Analyst Weigh In

HUM has been the subject of a number of research analyst reports. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a report on Monday, August 19th. Robert W. Baird initiated coverage on shares of Humana in a report on Thursday, May 30th. They set a “neutral” rating and a $374.00 price objective for the company. Oppenheimer lifted their price objective on shares of Humana from $370.00 to $400.00 and gave the stock an “outperform” rating in a report on Thursday, August 1st. Finally, Piper Sandler initiated coverage on shares of Humana in a report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 price objective for the company. Thirteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $396.35.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.